Champions Oncology - 53 Year Dividend History | CSBR
Historical dividend payout and yield for Champions Oncology (CSBR) since 1971. The current TTM dividend payout for Champions Oncology (CSBR) as of November 21, 2024 is $0.00. The current dividend yield for Champions Oncology as of November 21, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Drug Manufacturing |
$0.062B |
$0.050B |
|
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
